Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.
Aged
Aged, 80 and over
Balloon Occlusion
Carcinoma, Hepatocellular
/ blood supply
Chemoembolization, Therapeutic
Cisplatin
/ administration & dosage
Ethiodized Oil
/ administration & dosage
Female
Gelatin
/ administration & dosage
Humans
Liver
/ blood supply
Liver Neoplasms
/ blood supply
Male
Middle Aged
Retrospective Studies
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
11
2018
revised:
13
03
2019
accepted:
30
04
2019
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
18
12
2019
Statut:
epublish
Résumé
It is difficult to control small hepatocellular carcinoma (HCC) nodules adjacent to the Glisson sheath (GS) by trans-arterial chemoembolization (TACE) probably due to multiple small tumor feeders directly branching from the trunk artery. The purpose of this study was to conduct a retrospective evaluation of a new TACE technique called the repeated alternate infusion of cisplatin solution and gelatin slurry distal to balloon occlusion (RAIB-TACE), for the treatment of small HCC nodules adjacent to GS. Small nodules less than 4 cm attached to proximal portion of the subsegmental to lobar level portal branch were retrospectively selected. Between January 2011 and April 2014, 29 nodules in 29 patients were treated by super-selective lipiodol TACE/balloon-occluded TACE (B-TACE) (Lip-TACE group). Since April 2014, treatment protocols for small nodules adjacent to GS were changed, and 14 nodules in 12 patients were treated by RAIB-TACE (RAIB-TACE group). In RAIB-TACE group, alternate infusion of cisplatin solution and sparse gelatin slurry (mixture of 80 mg of gelatin fragments and 20 mL of contrast medium) were repeated until arterial flow was ceased. In Lip-TACE group, lipiodol was used as drug carrier and dense gelatin slurry (mixture of 80 mg of gelatin fragments and 2 mL of contrast medium) as embolization material. Dynamic CT/MRI was obtained 1-3 months after TACE, and response of each nodule was evaluated basing on modified RECIST criteria. In RAIB-TACE group, all 14 nodules (100%) were diagnosed as CR or PR. In Lip-TACE group, 18 of 29 (62.1%) were diagnosed as CR or PR. There was a statistically significant difference in objective response ratio between the groups (p=0.008, Fisher's test). Biloma (n=1) and benign stricture of the right hepatic duct (n=1) were seen in RAIB-TACE group. The biloma shrunk without treatment and the patient had no symptom, but the patient with biliary stricture repeated cholangitis and was treated by administration of antibiotics. The study results show that RAIB-TACE is more effective than lipiodol TACE/B-TACE for small hepatocellular carcinoma adjacent to GS. We speculate that one of the reasons to explain why Lip-TACE is inferior to RAIB-TACE is that viscous lipiodol or dense gelatin slurry could not flow into small tumor feeders effectively.
Identifiants
pubmed: 31211142
doi: 10.1155/2019/8350926
pmc: PMC6532302
doi:
Substances chimiques
Ethiodized Oil
8008-53-5
Gelatin
9000-70-8
Cisplatin
Q20Q21Q62J
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8350926Références
Hepatology. 2000 Feb;31(2):269-79
pubmed: 10655246
Ann Surg Oncol. 2000 Sep;7(8):593-600
pubmed: 11005558
J Vasc Interv Radiol. 2003 Dec;14(12):1535-42
pubmed: 14654488
Radiology. 2005 Oct;237(1):361-5
pubmed: 16118153
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):696-704
pubmed: 17497071
Jpn J Radiol. 2009 May;27(4):185-93
pubmed: 19499310
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Eur J Radiol. 2012 Sep;81(9):1976-9
pubmed: 21628086
Cardiovasc Intervent Radiol. 2012 Oct;35(5):980-5
pubmed: 22009576
J Vasc Interv Radiol. 2012 Oct;23(10):1278-85
pubmed: 22922041
Cardiovasc Intervent Radiol. 2013 Jun;36(3):706-13
pubmed: 22996589
J Vasc Interv Radiol. 2013 Aug;24(8):1235-40
pubmed: 23796857
Br J Cancer. 2013 Oct 1;109(7):1904-7
pubmed: 24008659
Jpn J Radiol. 2014 May;32(5):260-5
pubmed: 24615165
AJR Am J Roentgenol. 2014 Dec;203(6):W706-14
pubmed: 25415737
Oncology. 2014;87 Suppl 1:22-31
pubmed: 25427730
J Hepatol. 2015 May;62(5):1187-95
pubmed: 25681552
Hepatol Res. 2016 Mar;46(3):E100-4
pubmed: 25988271
Jpn J Radiol. 2015 Dec;33(12):790-4
pubmed: 26390870
Jpn J Clin Oncol. 2018 Feb 1;48(2):103-114
pubmed: 29253194
Nihon Igaku Hoshasen Gakkai Zasshi. 1987 Dec 25;47(12):1550-9
pubmed: 3452788
Radiology. 1983 May;147(2):357-64
pubmed: 6836115